1 – 10 of 21
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Histone lysine demethylase inhibition reprograms prostate cancer metabolism and mechanics
(
- Contribution to journal › Article
- 2021
-
Mark
Proteogenomic Workflow Reveals Molecular Phenotypes Related to Breast Cancer Mammographic Appearance
(
- Contribution to journal › Article
-
Mark
Regulatory interplay between mir-181a-5p and estrogen receptor signaling cascade in breast cancer
(
- Contribution to journal › Article
- 2019
-
Mark
Inhibition of histone demethylases LSD1 and UTX regulates ERα signaling in breast cancer
(
- Contribution to journal › Article
- 2017
-
Mark
Phosphoserine aminotransferase 1 is associated to poor outcome on tamoxifen therapy in recurrent breast cancer
(
- Contribution to journal › Article
- 2016
-
Mark
4-protein signature predicting tamoxifen treatment outcome in recurrent breast cancer
(
- Contribution to journal › Article
-
Mark
Annexin-A1 and caldesmon are associated with resistance to tamoxifen in estrogen receptor positive recurrent breast cancer
(
- Contribution to journal › Article
-
Mark
Targeted MS Assay Predicting Tamoxifen Resistance in Estrogen-Receptor-Positive Breast Cancer Tissues and Sera
(
- Contribution to journal › Article
-
Mark
The advantage of laser-capture microdissection over whole tissue analysis in proteomic profiling studies
(
- Contribution to journal › Article
-
Mark
Endocrine therapy resistance in estrogen receptor (ER)-positive breast cancer
(
- Contribution to journal › Scientific review